Contract Research Organization Julius Clinical (NL) appointed Bassem Saleh as its new Chief Executive Officer. His predecessor, Martijn Wallert, will become an advisor to the Executive Board.
https://european-biotechnology.com/wp-content/uploads/2025/10/eb.com_Julius_Clinical_CEO_Bassem_Saleh.jpg711632Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2025-10-07 08:56:342025-10-07 09:07:23New CEO takes over